158 related articles for article (PubMed ID: 9413105)
21. Maternal recognition of foetal infection with bovine virus diarrhoea virus (BVDV)--the bovine pestivirus.
Brownlie J; Hooper LB; Thompson I; Collins ME
Clin Diagn Virol; 1998 Jul; 10(2-3):141-50. PubMed ID: 9741639
[TBL] [Abstract][Full Text] [Related]
22. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
23. Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine.
Palomares RA; Marley SM; Givens MD; Gallardo RA; Brock KV
Theriogenology; 2013 May; 79(8):1184-95. PubMed ID: 23561853
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle.
Pecora A; Aguirreburualde MS; Aguirreburualde A; Leunda MR; Odeon A; Chiavenna S; Bochoeyer D; Spitteler M; Filippi JL; Dus Santos MJ; Levy SM; Wigdorovitz A
Vet Res Commun; 2012 Sep; 36(3):157-64. PubMed ID: 22639081
[TBL] [Abstract][Full Text] [Related]
25. Investigation of a dual fetal infection model with bovine viral diarrhoea viruses (BVDV)-1 and BVDV-2.
Makoschey B; Janssen MG
Arch Virol; 2011 Oct; 156(10):1831-3. PubMed ID: 21597952
[TBL] [Abstract][Full Text] [Related]
26. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine.
Brock KV; Cortese VS
Vet Ther; 2001; 2(4):354-60. PubMed ID: 19746658
[TBL] [Abstract][Full Text] [Related]
27. Virological and pathological findings in sheep fetuses following experimental infection of pregnant ewes with cytopathogenic-bovine-virus diarrhoea virus.
Hewicker-Trautwein M; Liess B; Frey HR; Trautwein G
Zentralbl Veterinarmed B; 1994 Jun; 41(4):264-76. PubMed ID: 7839747
[TBL] [Abstract][Full Text] [Related]
28. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
Walz PH; Riddell KP; Newcomer BW; Neill JD; Falkenberg SM; Cortese VS; Scruggs DW; Short TH
Vaccine; 2018 Jun; 36(26):3853-3860. PubMed ID: 29699786
[TBL] [Abstract][Full Text] [Related]
29. Foetal cross-protection experiments between type 1 and type 2 bovine viral diarrhoea virus in pregnant ewes.
Paton DJ; Sharp G; Ibata G
Vet Microbiol; 1999 Jan; 64(2-3):185-96. PubMed ID: 10028172
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
[TBL] [Abstract][Full Text] [Related]
31. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
[TBL] [Abstract][Full Text] [Related]
32. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
[TBL] [Abstract][Full Text] [Related]
33. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
Brock KV; McCarty K; Chase CC; Harland R
Vet Ther; 2006; 7(1):27-34. PubMed ID: 16598681
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle.
Talens LT; Beckenhauer WH; Thurber ET; Cooley AJ; Schultz RD
J Am Vet Med Assoc; 1989 May; 194(9):1273-80. PubMed ID: 2542202
[TBL] [Abstract][Full Text] [Related]
35. Experimental persistent infection with bovine viral diarrhea virus in white-tailed deer.
Passler T; Walz PH; Ditchkoff SS; Givens MD; Maxwell HS; Brock KV
Vet Microbiol; 2007 Jun; 122(3-4):350-6. PubMed ID: 17353103
[TBL] [Abstract][Full Text] [Related]
36. Rapid transplacental infection with bovine pestivirus following intranasal inoculation of ewes in early pregnancy.
Swasdipan S; Bielefeldt-Ohmann H; Phillips N; Kirkland PD; McGowan MR
Vet Pathol; 2001 May; 38(3):275-80. PubMed ID: 11355657
[TBL] [Abstract][Full Text] [Related]
37. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge.
Nobiron I; Thompson I; Brownlie J; Collins ME
Vaccine; 2003 May; 21(17-18):2082-92. PubMed ID: 12706698
[TBL] [Abstract][Full Text] [Related]
38. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
[TBL] [Abstract][Full Text] [Related]
39. Alterations in pregnancy-associated glycoprotein concentrations of pregnant sheep experimentally infected with bovine viral diarrhea virus.
Lear A; Pohler K; Sula MM; Kiupel M; Mulon PY; Caldwell M
Am J Vet Res; 2021 Jan; 82(1):63-70. PubMed ID: 33369498
[TBL] [Abstract][Full Text] [Related]
40. Prevention of fetal infection in heifers challenged with bovine viral diarrhoea virus type 1a by vaccination with a type 1c or type 1a vaccine.
Packianathan R; Clough WJ; Hodge A; Holz DK; Huang J; Bryant GL; Colantoni C
N Z Vet J; 2017 May; 65(3):134-139. PubMed ID: 28359226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
